A major international study led by UCL researchers has found that combining two cancer drugs could substantially slow the progression of a severe and often deadly form of prostate cancer in men with specific genetic mutations.
Published in Nature…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply